Respirology

Article	Citations
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease	125
O5‐5: Current smoking by socioeconomic status in a representative Japanese population	108
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis	87
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient	84
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis	69
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)	68
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure	67
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital	49
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy	48
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey	48
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study	47
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report	42
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer	41
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase	40
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures	39
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire	39
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements	35
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study	35
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity	34
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)	33
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy	33
P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma	32
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor	32
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?	32
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome	32

P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism	31
	31
Reassessing pyrazinamide: Disentangling the myth of dose‐dependent hepatotoxicity and advancing dosing strategies in elderly tuberculosis patients	31
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines	31
APSR 2024 Abstracts	30
Language concordance in healthcare: Beyond just talk	29
Limitations of Self‐Reported Data in Evaluating COPD Phenotypes and Cardiovascular Risk	29
Bayesian adaptive clinical trial designs for respiratory medicine	28
Omics technologies to study virus infection and chronic lung diseases	28
Proteomic and other ‘‐omic’ analyses to develop disease stage‐specific platforms and therapeutic strategies for COPD: It is about time	27
Improving support of informal carers of respiratory patients	26
Prevention of droplet dispersal with ‘e‐mask’: A new daily use endoscopic mask during bronchoscopy	26
Predicting malignant pleural effusion during diagnostic pleuroscopy with biopsy: A prospective multicentre study	26
Philip Morris International buys inhaler company Vectura to expand reach in electronic cigarettes	26
Contemporary Concise Review 2020: Asthma	25
Epilogue to contemporary perspectives in COPD: New Horizons	25
Decline in respiratory and cardiac admissions during the COVID‐19 pandemic: What is the role of common respiratory virus infections?	25
Asthma and landscape fire smoke: A Thoracic Society of Australia and New Zealand position statement	24
Influence of Staphylococcal enterotoxin‐specific IgE sensitization on therapeutic efficacy of omalizumab therapy in severe asthma	24
Long‐term impact of coal mine fire smoke on lung mechanics in exposed adults	24
Response to “Fixed CPAP at 10 cmH2O for OSA: A One‐Size‐Fits‐All Approach?”	24
Trends of global and regional aetiologies, risk factors and mortality of lower respiratory infections from 1990 to 2019: An analysis for the Global Burden of Disease Study 2019	23
Issue Information	23
	23
	22
O8‐2: Clinical impact by phenotyping empyema based on pleural fluid culture positivity and appearance: A 7‐year retrospective analysis	22
O23‐1: Clinical features of novel phenotype in pulmonary hypertension along with mild lung parenchymal change without severe ventilatory impairment	22
P5‐155: Legionella pneumophilia pneumonia with rapid clinical course in a lung cancer patient	20
P7‐43: The impact of fungal sensitization on clinical features in asthma and chronic pulmonary obstructive disease	20
P6‐9: A post covid activation of latent tuberculosis	19
P15‐3: Potential amelioration of pulmonary hypertension in COPD by budesonide/glycopyrronium/formoterol via central NFκB inflammatory signaling deactivation: In vivo mouse model	19
P2‐42: Effects of protease‐activated receptor antagonist on steroid insensitive airway inflammation induced by LPS in mice	19
P12‐32: Cryo‐recanalization in a case of recurrent endobronchial diffuse large B‐cell lymphoma	18
P16‐86: Tolerability and safety of nintedanib for idiopathic pulmonary fibrosis and progressive fibrosing interstitial lung diseases	18
P7‐49: Clinical experience of budesonide/glycopyrrolate/formoterol in patients with chronic obstructive pulmonary disease	17
P5‐39: Impact of chronic co‐infection in pulmonary Mycobacterium avium complex disease after commencing treatment	17
P16‐71: Factors associated with pulmonary function decline in patients with rheumatoid arthritis‐associated interstitial lung disease	17
O9‐1: Urticaria—A Major systemic drug reaction under 1HP tuberculosis prevention in non‐HIV population	17
P16‐49: Analysis of lymphocyte fractions in bronchoalveolar lavage fluid in chronic eosinophilic pneumonia	16
P6‐43: Multicenter Prospective Study on Gouty Arthritis and Predictors of Outcomes among Filipino Patients on Anti‐Tuberculosis Treatment	16
P4‐23: A case report of bronchial anthracofibrosis – A Sri Lankan experience	16
P8‐18: Analysis of trace element concentrations and relationship between trace element and prognosis in lung cancer patients	16
O2‐2: Development and implementation of an aspiration pneumonia diagnostic algorithm for the practical application of the JRS guidelines	16
P16‐48: The prognostic marker of polymyxin B‐immobilized fiber column‐direct hemoperfusion in patients who developed acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia	16
P16‐96: Efficacy and safety of combination therapy of antifibrotic agents in patients with idiopathic pulmonary fibrosis	16
P2‐46: Effect of high fat diet on the severity and repair of lung fibrosis in mice	15
P9‐55: Inhaler techniques and confidence of use of inhalers	15
P1‐12: Eosinophilic granulomatosis with polyangiitis (Churg Strauss syndrome) presenting as acute polyneuropathy mimicking Guillain‐Barre syndrome ‐ A case report	15
P12‐24: Tracheo‐ bronchial stenosis‐ different clinical presentations and individualised treatment approach	15
P6‐29: A case of elderly female with unresponsive anti‐tuberculosis therapy in rural area	15

Predicting Failure: Can Blood Biomarkers Identify Likely Treatment Non‐Responders in IPF?	14
Enhancing COPD Care for Women: A Predictive Tool for Palliative Needs	14
P1‐83: A case report of primi 30 weeks of pregnancy with COVID‐19 pneumonia with dengue fever	14
Issue Information	14
	14
A New Opportunity in Respirology	14
Unravelling the effects of omalizumab on fibrocytes	13
Singing in and out of COVID	13
Allele‐specific micro‐RNA‐mediated regulation of ADAM33 in childhood allergic asthma	13
From light to sound: Ultrasound outshines Light's criteria for pleural effusions classification	13
The chicken or the egg: Sleep or physical activity?	13
Obesity is a major contributing cause of breathlessness in the population	13
Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis	13
Letter from Canada: Global warming and wildfire smoke pollution emerging as major threats to respiratory health	12
Safety and efficacy of bronchial thermoplasty in Australia 5 years post‐procedure	12
Stepping down for mild asthma and disadvantages of the ‘as‐needed’ strategy—Perspectives from a developing country	12
Associations of early life and childhood risk factors with obstructive sleep apnoea in middle‐age	12
Adding some NOVELTY to treatable traits	12
Smoking, respiratory symptoms, lung function and life expectancy: A longitudinal study of ageing	11
Antifibrotics and lung transplantation: A Spanish multicentre case‐controlled study	11
P5‐48: Shrot versus long antibiotic course for pleural infection management: A randomised trial	11
Proposed quality indicators and recommended standard reporting items in performance of EBUS bronchoscopy: An official World Association for Bronchology and Interventional Pulmonology E	11
Abstract	11
Effect of antifibrotic agents on postoperative complications after lung transplantation for idiopathic pulmonary fibrosis	11
P16‐16: The role of statins on the risk of the cancer among the interstitial lung diseases and pulmonary fibrosis: A time‐dependent in propensity‐matched general population study focus on the immunolo	10
P8‐4: An integrated analysis of the competing endogenous RNA network associated of prognosis of stage I lung adenocarcinoma	10
P6‐22: Characteristics of pulmonary tuberculosis with delayed diagnosis in our hospital	10
P3‐13: IL‐17A acutely modulates airway smooth muscle contractility by PKC‐alpha‐mediated RhoA activation	10
P9‐21: Inhaled corticosteroids for all asthma	10
P8‐50: Lung cancer, as a risk factor for abdominal aortic aneurysm (AAA)	10
O4‐2: Serum albumin in furry animals as a cross‐reactive component may cause more severe allergic symptoms	10
P7‐5: Sex‐specific differences of prevalence and risk factors for chronic obstructive pulmonary disease in subjects with preserved ratio impaired spirometry	10
O1‐4: Prognosis of Japanese patients with late‐onset non‐infectious pulmonary complications after hematopoietic stem cell transplantation registered for lung transplantation	10
P16‐55: Additional effects of macrolides on steroid pulse therapy in patients with acute exacerbation of interstitial lung disease	10
P8‐31: Prospective observational study of sequential afatinib and osimertinib in NSCLC patients with EGFR mutation: Gio‐Tag Japan	10
P4‐24: Respiratory symptoms and lung function among active smokers in Indonesian college students	10
P9‐80: Exposures to cigarette smoke and house dust in relation to child asthma at Harum Melati Clinic, Pringsewu Regency, Lampung, Indonesia	10
P12‐36: Bronchoscopic cryo‐excision of a large chondroid hemartoma presented as right middle lobe collapse in a 63 yrs gentleman	10
P9‐77: The correlation of childhood asthma and family history of atopy in Harum Melati clinic, Pringsewu, Lampung, INDONESIA	9
P7‐29: Muscle mass evaluation using body composition analysis for COPD patients	9
P8‐86: Puncture frequency is the determinants of iatrogenic pneumothorax in preoperative pulmonary nodule localization: A propensity matched study	9
	9
P16‐83: HRCT scoring focused on ground‐glass opacity, perilobular opacity, airspace consolidation, and interlobular septal thickening is useful for interstitial lung disease accompanied by anti‐MDA5 a	9
P5‐89: Effectiveness of a questionnaire to screen COVID‐19	9
P1‐94: The challenges of patients that with home using long term oxygen therapy under coronavirus pandemic	9
Corrigendum	9
Add‐On Dextromethorphan Improves the Effects of Pirfenidone in Bleomycin‐Treated Mice and Patients With Pulmonary Fibrosis	9
P16‐50: Clinical features of pleuroparenchymal fibroelastosis: Idiopathic versus secondary phenotype	9
P16‐34: Clinical investigation of the relationship between interstitial lung disease and obstructive sleep apnea	9
Letter from Vietnam	9
Transitional Lung Function Paths in Young Adults: More Opportunities for Prevention?	9
P5‐37: Community‐acquired respiratory virus cases mimic COVID‐19 on lung computed tomography	8
P5‐149: Investigation of antibody level by the presence or absence of side effects after the new coronavirus vaccine	8
Abstracts	8
Issue Information	8
Issue Information	8
P5‐151: Changes over time in six‐minute walk test and the SGRQ scores in patients with nontuberculous mycobacterial pulmonary disease	8
P5‐57: Comparison of chest HRCT findings between COVID‐19 pneumonia and anti‐MDA5 antibody‐positive interstitial pneumonia by computer‐based quantitative CT image analysis	8
Thoracic Society of Australia and New Zealand (TSANZ) Is Abrogating Its Leadership Role in Asia‐Pacific	8
Issue Information	8
P3‐9: Allergy in IgG4‐related disease	8
P5‐25: Spontaneous development of pneumocystis pneumonia in mice lacking death ligand‐induced apoptosis and necroptosis	8
	8
P6‐65: A case of tuberculosis infection with a particular clinical course and difficulty in treatment	8
Correction to “Predictive role of neutrophil‐percentage‐to‐albumin, neutrophil‐to‐lymphocyte and eosinophil‐to‐lymphocyte ratios for mortality in patients with COPD: Evidence from NHAN	7
Letter from Australia	7
An additional mechanism enhancing exercise tolerance in interstitial lung disease with high‐flow nasal cannula	7
Corrigendum	7
Sleep medicine is more than just obstructive sleep apnoea	7
A snorkel mask with a 3D‐printed adaptor to HEPA filter was used in a COVID‐19 emergency ward to provide safe respiratory support	7
A Comprehensive Review of Interstitial Lung Abnormalities	7
Author Index	7
Uncontrolled mild‐to‐moderate asthma may not be mild or moderate, or even asthma: The benefits of early phenotyping	7
Issue Information	7
Laryngeal hypersensitivity and abnormal cough response during mannitol bronchoprovocation challenge	7
Promotion of physical activity after hospitalization for COPD exacerbation: Aids and barriers	7
The 63rd Annual Meeting of the Japanese Respiratory Society	7
Efficacy and safety of virtual bronchoscopic navigation with fused fluoroscopy and vessel mapping for access of pulmonary lesions	7
Chest x‐ray has low sensitivity to detect silicosis in artificial stone benchtop industry workers	7
A New Era in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis	7

My Lungs Have Feelings Too!	7
Severe asthma, more than that?	7
The Olympics have arrived: The challenge of exercise‐induced bronchoconstriction in athletes	7
P7‐39: Evaluation of the effect of ICS containing triple therapy with LAMA/LABA in comparison with LAMA/LABA in COPD patients	6
P6‐61: Association of serum antibodies against the Mycobacterium avium complex with hemoptysis	6
P8‐128: Phase II trial of pembrolizumab in poor performance status NSCLC patients with PD‐L1 ≥ 50%: OLCSG 1801	6
O22‐5: Complete pulmonary function profiles of 267 post COVID patients with exertional dyspnea in Bangladesh	6
P2‐39: Assessment of inter‐lobe biological diversity in the lung by DNA methylation profiles in autopsy cases	6
P6‐23: Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and pleural fluid lactate dehydrogenase/ADA ratio of tuberculous and non‐tuberculous pleural disease	6
P7‐33: The different significance between sedentary time and high‐intensity physical activities in patients with stable COPD	6
P9‐39: Efficacy of vitamin d supplementation in children with asthma and vitamin D deficiency: A systematic review	6
P8‐69: Clinical study of chemotherapy with an immune checkpoint inhibitor combination chemotherapy in advanced small cell lung cancer	6
P2‐33: Blocking MMP‐12‐modulated epithelial‐mesenchymal transition by repurposing penfluridol retsrains lung adenocarcinoma metastasis via UPA/UPAR/TGF‐Β/AKT pathway	6
P1‐48: Metabolism of traditional Chinese medicine in the treatment of allergic rhinitis	6
Author Index	6
P5‐56: Predictive model for the development of critical coronavirus disease 2019 in Japan	6
P8‐170: A patient with ALK translocation‐positive lung adenocarcinoma in whom an EGFR mutation developed during the treatment with ALK inhibitors	6
P3‐1: Differential model of the deep convolutional neural network between sarcoidosis and lymphoma in 18F‐FDG‐PET/CT	6
P3‐2: Impact of air pollutant of polycyclic aromatic hydrocarbons (PAHS) on the yearly decline of pulmonary function in asthmatics sensitized to house dust mite (HDM)	6
P10‐14: Long term follow‐up in pediatric OHS/OSA treated conservatively: Survival tips beyond home ventilation	6
P16‐56: The effect of pulmonary macrophage transplantation on mice with bleomycin‐induced pulmonary fibrosis	6
	6
P7‐6: The association between alkaline phosphatase and COPD symptoms, severity, and exacerbation	6
P8‐145: Successful immune checkpoint inhibition in an EGFR‐TKI‐refractory lung cancer with EGFR mutation and transformation	5
	5
COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography	5
Association of short‐term exposure to PM1 with hospital admission from total and cause‐specific respiratory diseases	5
Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy	5
Exercise tolerance in mild chronic obstructive pulmonary disease: Finding the missing link is what provides clinical value in pulmonary function tests	5
Attenuation of exertional desaturation and preference for interval exercise compared to continuous exercise in people with interstitial lung disease	5
	5
Letter from the United States: An update on the New York experience with COVID‐19	5
P16‐67: Kinetic changes of serum KL‐6 levels predict disease progression in systemic sclerosis‐associated interstitial lung disease	5
P8‐95: Correlation of neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR) and carcinoembryonic antigen (CEA) with overall survival: Review of patients with non‐small cell carcinoma (NSC	5
Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe	5
Hansen's disease and the first patient disease Registry	5
The United Nations Framework Convention on Climate Change (UNFCCC) 28th Conference of the Parties, Dubai (COP28): Implications for lung disease	5
Transformative radiology: Chest imaging is being re‐defined	5
Issue Information	5
Author Index	5
P8‐80: Bevacizumab suppresses epithelial‐to‐mesenchymal transition in EGFR‐mutant lung cancer	5
P6‐2: To study the efficacy and safety of bedaquiline plus optimized background regimen and high dose moxifloxacin plus optimized background regimen in drug resistant pulmonary tuberculosis‐A prospect	5
Leading Women in Respiratory Clinical Sciences: Letter From Japan	5
Letter from Korea	5
Presence of anti‐modified protein antibodies in idiopathic pulmonary fibrosis	5
Validation of the clinical utility of sGaw as a response variable in methacholine challenge testing	5
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study	5
Correction to APSR Annual Conference ‐ 28th Congress of the Asian Pacific Society of Respirology, 7–10 November 2024, Hong Kong. Respirology 29 (Suppl. 3)	5
P13‐3: Withdrawn	5
Predictors of psychological stress in silica‐exposed workers in the artificial stone benchtop industry	4
P12‐28: Bronchiolitis obliterans after bone marrow transplantation diagnosed by ultrathin bronchoscopy: A case report	4
P1‐77: Long‐COVID syndrome associated with COVID‐19 pneumonia	4
	4
P16‐62: The prognostic factor of idiopathic interstitial pneumonias patients complicated with pneumothorax: A multicenter retrospective study	4
P5‐68: The use of an institutionalized respiratory protocol as a decision‐making tool improved outcomes among severe and critically‐ill COVID‐19 patients in Perpetual Succour Hospital	4
P5‐111: SARS‐CoV‐2 PCR and antigen positivity continued for 3 months after treatment for severe COVID‐19: Case report	4
P5‐85: Staged treatment of middle lobe lung gangrene using the vacuum‐assisted closure therapy in a patient with severe COVID‐19 pneumonia	4
P13‐1: Chest X‐ray findings of coronavirus‐19 disease in patients age 0 to 18 years old admitted at Chong Hua Hospital from March 2020 to February 2021	4
P7‐66: Clinical inertia in the management of COPD: A review of the literature	4
P10‐20: Sleep and the usage of smart devices among Sri Lankan doctors	4
O4‐5: Combination of tryptase and IL‐33 in bronchoalveolar lavage fluid may predict the types of eosinophilic pneumonia and disease recurrence	4
P16‐97: Secondary organizing pneumonia following COVID‐19 infection	4
Feasibility of a Modified Bronchoscopic Transparenchymal Nodule Access Technique (‘Essen Tunnel’) for Improving the Diagnosis of Intraparenchymal Pulmonary Lesions	4
O17‐4: Novel predictive biomarkers for mepolizumab treatment in patients with severe asthma	4
P6‐4: Endobronchial mass occurred during treatment of tuberculosis: Two cases	4
Issue Information	4
P16‐53: Effectiveness of antifibrotic treatment for acute exacerbation of idiopathic pulmonary fibrosis	4
Issue Information	4
P8‐139: A case of pulmonary mucoepidermoid carcinoma treated with carboplatin, nab‐paclitaxel, and pembrolizumab	4
P8‐30: Usefulness of pulmonary rehabilitation in non‐small cell lung cancer patients based on pulmonary function tests and muscle index analysis using computed tomography images	4
P6‐44: Case report of a newly diagnosed bacteriologically confirmed pulmonary tuberculosis in a patient with COVID‐19 critical infection	4
P9‐67: Adherence to inhaled corticosteroids in working‐age patients with asthma: A non‐interventional study with secondary use of data	4
P8‐10: Minichromosome maintenance complex component (MCM) genes in lung adenocarcinoma: MCM‐family acts as a potential therapeutic target	4
O2‐4: Prevalence, characteristics, risk factors and disease course of ulcerative colitis‐related pulmonary manifestations	4
Global, regional and national burden of chronic obstructive pulmonary disease over a 30‐year period: Estimates from the 1990 to 2019 Global Burden of Disease Study	4
High Flow Nasal Oxygen and Low Flow Oxygen Are Equally Effective in Providing Oxygenation During Bronchoscopy Under Conscious Sedation: A Randomised Controlled Trial	4
P12‐3: Diagnostic efficacy of cryobiopsy for peripheral pulmonary lesions with ground‐glass opacity: A propensity score‐matched analysis	4
Issue Information	4
Issue Information	4
P5‐114: A young lady with bones in the lungs –A case of diffuse pulmonary fibro ossification complicated with fungal infection	4
P12‐38: A young woman with bilateral primary spontaneous pneumothorax	4
P8‐84: S‐1 reduces myeloid‐derived suppressor cells in murine mesothelioma model and enhances the anti‐tumor activity of anti‐PD‐1 antibody	4
P15‐4: Pulmonary vasculopathy in pulmonary hypertension with interstitial lung disease: A morphometric study of autopsy cases	4
Innovations in thoracic imaging: CT, radiomics, AI and x‐ray velocimetry	4
P2‐15: An HTERT/CDK4‐immortalized normal human bronchial epithelial cell line is highly resistant to mutant KRAS‐induced senescence	4
P1‐62: Elderly sarcoidosis in Japan	4
O18‐4: Non‐invasive ventilation improves persistent tachycardia in a case of mitochondrial myopathy	4
P8‐67: A retrospective study of recurrence patterns in chemoradiotherapy using volumetric modulated arc therapy for locally advanced non‐small cell lung cancer	3
P8‐12: The relationship between lung microbiota and pathologic subtype with prognosis	3
P7‐25: The mortality difference in chronic obstructive pulmonary disease: Ever‐smoker versus never‐smoker	3
P8‐13: The gut microbiome as a new marker of tumor progression among female never‐smokers with lung adenocarcinoma	3
P5‐78: Pulmonary nocardiosis with osteolytic lesions mimicking lung cancer	3
P8‐64: Optimal dose of amrubicin for previously treated small‐cell lung cancer: A retrospective study	3
P6‐18: Endobronchial ultrasound transbronchial aspiration biopsy (EBUS‐TBNA) in the diagnosis of mediastinal mass of unknown etiology: A case series	3
P4‐26: Withdrawn	3